Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa

Summary

A phase II, comparative, open label, prospective, multicentre clinical trial where each patient will undergo two procedures; implant of a patch of cultured chimeric skin (experimental therapy) in a half of the skin lesion and an occlusive non-adherent dressing (control) in the other half for 12 months of follow-up in two Spanish centres.

Timeline

Start

2006-12

Primary completion

2010-05

Completion

2010-05

Drugs

Indications